294 related articles for article (PubMed ID: 30185612)
1. Disordered haematopoiesis and cardiovascular disease: a focus on myelopoiesis.
Dragoljevic D; Westerterp M; Veiga CB; Nagareddy P; Murphy AJ
Clin Sci (Lond); 2018 Sep; 132(17):1889-1899. PubMed ID: 30185612
[TBL] [Abstract][Full Text] [Related]
2. Disordered haematopoiesis and athero-thrombosis.
Murphy AJ; Tall AR
Eur Heart J; 2016 Apr; 37(14):1113-21. PubMed ID: 26869607
[TBL] [Abstract][Full Text] [Related]
3. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
4. Assessment of medullary and extramedullary myelopoiesis in cardiovascular diseases.
Abdali A; Marinković G
Pharmacol Res; 2021 Jul; 169():105663. PubMed ID: 33979688
[TBL] [Abstract][Full Text] [Related]
5. The role of clonal haematopoiesis in cardiovascular diseases: epidemiology and experimental studies.
Min KD; Kour A; Sano S; Walsh K
J Intern Med; 2020 Nov; 288(5):507-517. PubMed ID: 32715520
[TBL] [Abstract][Full Text] [Related]
6. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
Svensson EC; Madar A; Campbell CD; He Y; Sultan M; Healey ML; Xu H; D'Aco K; Fernandez A; Wache-Mainier C; Libby P; Ridker PM; Beste MT; Basson CT
JAMA Cardiol; 2022 May; 7(5):521-528. PubMed ID: 35385050
[TBL] [Abstract][Full Text] [Related]
7. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
[TBL] [Abstract][Full Text] [Related]
8. Clonal haematopoiesis and cardiovascular diseases: A growing relationship.
Fawaz S; Mansier O; Pucheu Y; Marti S; Leroy H; Gaufroy A; Broitman J; James C; Couffinhal T
Arch Cardiovasc Dis; 2021 Apr; 114(4):316-324. PubMed ID: 33714721
[TBL] [Abstract][Full Text] [Related]
9. Interplay between Clonal Hematopoiesis of Indeterminate Potential and Metabolism.
Lee MKS; Dragoljevic D; Bertuzzo Veiga C; Wang N; Yvan-Charvet L; Murphy AJ
Trends Endocrinol Metab; 2020 Jul; 31(7):525-535. PubMed ID: 32521236
[TBL] [Abstract][Full Text] [Related]
10. A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease.
Ehlert CA; Hilgendorf I
Hamostaseologie; 2021 Dec; 41(6):443-446. PubMed ID: 34942657
[TBL] [Abstract][Full Text] [Related]
11. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
Cobo I; Tanaka T; Glass CK; Yeang C
Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
[TBL] [Abstract][Full Text] [Related]
12. The haematopoietic stem cell niche: a new player in cardiovascular disease?
Al-Sharea A; Lee MKS; Purton LE; Hawkins ED; Murphy AJ
Cardiovasc Res; 2019 Feb; 115(2):277-291. PubMed ID: 30590405
[TBL] [Abstract][Full Text] [Related]
13. Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis.
Flynn MC; Pernes G; Lee MKS; Nagareddy PR; Murphy AJ
Front Pharmacol; 2019; 10():666. PubMed ID: 31249530
[TBL] [Abstract][Full Text] [Related]
14. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.
Jaiswal S; Libby P
Nat Rev Cardiol; 2020 Mar; 17(3):137-144. PubMed ID: 31406340
[TBL] [Abstract][Full Text] [Related]
15. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
Front Immunol; 2019; 10():1378. PubMed ID: 31275317
[TBL] [Abstract][Full Text] [Related]
16. Clonal hematopoiesis and vascular disease.
Amancherla K; Wells JA; Bick AG
Semin Immunopathol; 2022 May; 44(3):303-308. PubMed ID: 35122117
[TBL] [Abstract][Full Text] [Related]
17. Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis.
Lee MKS; Cooney OD; Lin X; Nadarajah S; Dragoljevic D; Huynh K; Onda DA; Galic S; Meikle PJ; Edlund T; Fullerton MD; Kemp BE; Murphy AJ; Loh K
Mol Metab; 2022 Jul; 61():101514. PubMed ID: 35562083
[TBL] [Abstract][Full Text] [Related]
18. Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure.
Mooney L; Goodyear CS; Chandra T; Kirschner K; Copland M; Petrie MC; Lang NN
Clin Sci (Lond); 2021 Apr; 135(7):991-1007. PubMed ID: 33861346
[TBL] [Abstract][Full Text] [Related]
19. Sleep modulates haematopoiesis and protects against atherosclerosis.
McAlpine CS; Kiss MG; Rattik S; He S; Vassalli A; Valet C; Anzai A; Chan CT; Mindur JE; Kahles F; Poller WC; Frodermann V; Fenn AM; Gregory AF; Halle L; Iwamoto Y; Hoyer FF; Binder CJ; Libby P; Tafti M; Scammell TE; Nahrendorf M; Swirski FK
Nature; 2019 Feb; 566(7744):383-387. PubMed ID: 30760925
[TBL] [Abstract][Full Text] [Related]
20. A positive feedback loop between IL-1β, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages.
Sieve I; Ricke-Hoch M; Kasten M; Battmer K; Stapel B; Falk CS; Leisegang MS; Haverich A; Scherr M; Hilfiker-Kleiner D
Vascul Pharmacol; 2018 Apr; 103-105():16-28. PubMed ID: 29371126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
